Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 63 Osteosarcoma 16 Leiomyosarcoma 16 Neoplasm Metastasis 10 Pancreatic Neoplasms 9 Breast Neoplasms 9 Bone Neoplasms 8 Rhabdomyosarcoma 6 Ovarian Neoplasms 6 Neoplasms 6 Colorectal Neoplasms 6 Small Cell Lung Carcinoma 5 Sarcoma, Ewing 5 Liposarcoma 5 Head and Neck Neoplasms 5 Colonic Neoplasms 5 Sarcoma, Synovial 4 Prostatic Neoplasms 4 Melanoma 4 Histiocytoma, Malignant Fibrous 4 Hemangiosarcoma 4 Chondrosarcoma 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Recurrence 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Gastrointestinal Stromal Tumors 3 Esophageal Neoplasms 3 Dermatofibrosarcoma 3

Interventions

Specimen Handling 9 Paclitaxel 7 Magnetic Resonance Spectroscopy 6 Carboplatin 6 Biopsy 6 Nivolumab 5 pembrolizumab 3 olaparib 3 X-Rays 3 durvalumab 2 ceralasertib 2 cediranib 2 Taxes 2 Immunoglobulin G 2 trastuzumab deruxtecan 1 sargramostim 1 rucaparib 1 ribociclib 1 rebastinib 1 pelcitoclax 1 pazopanib 1 pamiparib 1 liposomal doxorubicin 1 cobimetinib 1 capivasertib 1 cabozantinib 1 belinostat 1 atezolizumab 1 apatinib 1 Trabectedin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinosarcoma × Gemcitabine × Sarcoma × Clear all

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡